Pfizer and BioNTech Claim, Omicron Booster Is Stronger , Than Original Shot.
The companies made the claim via a press release issued on Nov.
4.
Based on two company-led studies, the results have not been confirmed by independent scientists.
Pfizer and BioNTech claim the results show their booster vaccine can be up to four times more effective for adults over 55.
As we head into the holiday season, we hope these updated data will encourage people to seek out a COVID-19 bivalent booster as soon as they are eligible... , Albert Bourla, Pfizer Chairman and CEO, via Pfizer Press Release.
... in order to maintain high levels of protection against the widely circulating Omicron BA.4 and BA.5 sublineages, Albert Bourla, Pfizer Chairman and CEO, via Pfizer Press Release.
These updated data also provide confidence in the adaptability of our mRNA platform... , Albert Bourla, Pfizer Chairman and CEO, via Pfizer Press Release.
... and our ability to rapidly update the vaccine to match the most prevalent strains each season, Albert Bourla, Pfizer Chairman and CEO, via Pfizer Press Release.
BioNTech's CEO stated that the companies will continue to tailor their vaccines to new COVID variants and subvariants.
In the next step and as part of our science-based approach we will continue to evaluate the cross-neutralization of the adapted vaccine against new variants and sublineages.
, Professor Ugur Sahin, BioNTech CEO and Co-founder, via Pfizer Press Release.
Our goal is to provide broader immunity against COVID-19 caused by SARS-CoV-2, including Omicron and other circulating strains, Professor Ugur Sahin, BioNTech CEO and Co-founder, via Pfizer Press Release.
According to the Pfizer press release, .
... the company has shared its data with both the U.S. Food and Drug Administration and the European Medicines Agency
